Sacubitril/Valsartan in Heart Failure and Deterioration in eGFR: Slow and Steady Win the Race

JACC Heart Fail. 2024 Oct;12(10):1704-1706. doi: 10.1016/j.jchf.2024.07.010. Epub 2024 Aug 28.
No abstract available

Keywords: deterioration; heart failure; sacubitril/valsartan.

Publication types

  • Editorial

MeSH terms

  • Aminobutyrates* / therapeutic use
  • Angiotensin Receptor Antagonists* / therapeutic use
  • Biphenyl Compounds* / therapeutic use
  • Drug Combinations*
  • Glomerular Filtration Rate*
  • Heart Failure* / drug therapy
  • Heart Failure* / physiopathology
  • Humans
  • Tetrazoles* / therapeutic use
  • Valsartan*

Substances

  • Valsartan
  • Biphenyl Compounds
  • Aminobutyrates
  • sacubitril and valsartan sodium hydrate drug combination
  • Drug Combinations
  • Angiotensin Receptor Antagonists
  • Tetrazoles